World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
35326
World Ranking
13473
National Ranking
6849

Ronny Drapkin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ronny Drapkin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 725 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ronny Drapkin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ronny Drapkin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ronny Drapkin is affiliated with the University of Pennsylvania in the United States. Their research spans multiple interconnected fields, primarily focusing on biochemistry, genetics, molecular biology, and medicine. Drapkin's work delves deeply into molecular biology and its applications in oncology and reproductive medicine.

The scientist has contributed extensively to several topics within cancer research and therapy, concentrating on areas such as:

  • Ovarian cancer diagnosis and treatment
  • Cancer, stress, anesthesia, and immune response
  • RNA modifications and cancer
  • PARP inhibition in cancer therapy
  • Chromatin remodeling and cancer
  • Cancer mechanisms and therapy
  • Cancer-related molecular mechanisms research

Some of the recent publications by Ronny Drapkin include:

  • "Nociceptor neurons affect cancer immunosurveillance," 2022, published in Nature
  • "Tumor innervation: peripheral nerves take control of the tumor microenvironment," 2021, published in Journal of Clinical Investigation
  • "Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma," 2021, published in Nature Cancer
  • "Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer," 2021, published in Gynecologic Oncology
  • "Tumor Innervation: Cancer Has Some Nerve," 2020, published in Trends in cancer

Drapkin frequently publishes in prominent venues, including:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research
  • Gynecologic Oncology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature

Collaboration is a significant aspect of Drapkin's research activities. Frequent co-authors include:

  • Euihye Jung
  • Matthew Knarr
  • Hunter D. Reavis
  • Paola D. Vermeer
  • Fiona Simpkins

Through their body of work, Drapkin contributes to a nuanced understanding of cancer biology at the molecular level, combining insights from genetics, immunology, and therapeutic strategies. Their research demonstrates a multidisciplinary approach to cancer treatment development and underlying molecular mechanisms.

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing

    Chryssa Kanellopoulou;Stefan A. Muljo;Andrew L. Kung;Shridar Ganesan

  • Rethinking ovarian cancer: recommendations for improving outcomes

    Sebastian Vaughan;Jermaine I. Coward;Robert C. Bast;Andy Berchuck

  • Whole-genome characterization of chemoresistant ovarian cancer

    Ann-Marie Patch;Ann-Marie Patch;Elizabeth Christie;Dariush Etemadmoghadam;Dariush Etemadmoghadam;Dale W. Garsed

  • Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

    David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria

  • 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

    Peter Bouwman;Amal Mahmoud Aly;Jose M. Escandell;Mark Pieterse

  • A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

    Y Lee;A Miron;R Drapkin;M R Nucci

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

    Ronny Drapkin;Hans Henning von Horsten;Yafang Lin;Samuel C. Mok

  • High grade serous ovarian carcinomas originate in the fallopian tube

    S. Intidhar Labidi-Galy;S. Intidhar Labidi-Galy;Eniko Papp;Dorothy Hallberg;Noushin Niknafs;Noushin Niknafs

  • Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

    Triona Ni Chonghaile;Kristopher A. Sarosiek;Thanh Trang Vo;Jeremy A. Ryan

  • Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

    Roel G.W. Verhaak;Pablo Tamayo;Ji Yeon Yang;Diana Hubbard

  • Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models

    Ruth Perets;Gregory A. Wyant;Katherine W. Muto;Jonathan G. Bijron

  • The distal fallopian tube: a new model for pelvic serous carcinogenesis.

    Christopher P. Crum;Ronny Drapkin;Alexander Miron;Tan A. Ince

  • A recurrent mutation in PALB2 in Finnish cancer families

    Hannele Erkko;Bing Xia;Jenni Nikkilä;Johanna Schleutker

  • New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact

    Keren Levanon;Christopher Crum;Ronny Drapkin

  • Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

    Hiu Wing Cheung;Glenn S. Cowley;Barbara A. Weir;Jesse S. Boehm

  • A comprehensive analysis of PAX8 expression in human epithelial tumors.

    Anna R. Laury;Ruth Perets;Huiying Piao;Jeffrey F. Krane

  • Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer

    Christopher P. Crum;Ronny Drapkin;David Kindelberger;Fabiola Medeiros

  • The p400 complex is an essential E1A transformation target.

    Miriam Fuchs;Jill Gerber;Ronny Drapkin;Ronny Drapkin;Said Sif

Frequent Co-Authors

Ursula A. Matulonis
Ursula A. Matulonis Harvard University
Christopher P. Crum
Christopher P. Crum Brigham and Women's Hospital
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
David D.L. Bowtell
David D.L. Bowtell Peter MacCallum Cancer Centre
David M. Livingston
David M. Livingston Harvard University
Danny Reinberg
Danny Reinberg University of Miami
Beth Y. Karlan
Beth Y. Karlan University of California, Los Angeles
Joan S. Brugge
Joan S. Brugge Harvard University
William C. Hahn
William C. Hahn Dana-Farber Cancer Institute
Adam R. Karpf
Adam R. Karpf University of Nebraska Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine or healthcare doesn’t always require a traditional path. Many students pursue nursing or administrative healthcare roles through flexible online programs. For those seeking to minimize costs, discovering the cheapest online bsn programs can significantly reduce student debt while progressing toward a bachelor’s degree in nursing.

Non-nurses who hold a bachelor’s degree in another field may be interested in online direct entry msn programs for non-nurses. These programs offer a fast track to advanced nursing roles and can open professional doors in just a few years.

If you’re concerned about entry requirements, you might want to research what is the easiest nursing program to get into. These schools may offer more accessible admissions, making it easier for aspiring healthcare professionals to get started.

Not all healthcare careers require direct patient care. Administrative fields like medical billing and coding are in high demand and can often be pursued via distance learning. Look into online medical billing and coding with financial aid for a cost-effective way to enter the healthcare sector.

Best Scientists Citing Ronny Drapkin

Trending Scientists

Recently Published Articles